Skip to search formSkip to main contentSkip to account menu

Hallucinogens

Known as: Psychotomimetic Agents, psychedelic drug, Hallucinogenic Agents 
Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the… 
National Institutes of Health

Related topics

Related topics

35 relations

Narrower (19)

2,5-Dimethoxy-4-methylamphetamine2,5-dimethoxy-4-bromoamphetamine3,4-Methylenedioxyamphetamine4-iodo-2,5-dimethoxyphenylisopropylamine
Expand
CannabinoidsCannabisCholinergic AntagonistsHallucinations
Expand

Broader (3)

Central Nervous System AgentsPharmaceutical Preparationspsychopharmacologic agent

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Psychedelic drugs have a long history of use in healing ceremonies, but despite renewed interest in their therapeutic potential… 
Highly Cited
2011
Highly Cited
2011
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
A large body of evidence, including longitudinal analyses of personality change, suggests that core personality traits are… 
Highly Cited
2009
Highly Cited
2009
The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
The sigma-1 receptor is widely distributed in the central nervous system and periphery. Originally mischaracterized as an opioid… 
Review
2008
Review
2008
Human hallucinogen research: guidelines for safety
There has recently been a renewal of human research with classical hallucinogens (psychedelics). This paper first briefly… 
Highly Cited
2007
Highly Cited
2007
Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior
Highly Cited
2003
Highly Cited
2003
Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins.
OBJECTIVE Data on use and misuse of six classes of illicit substances by male twin pairs were used to examine whether genetic and… 
Highly Cited
1998
Highly Cited
1998
Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities.
BACKGROUND Previous research has demonstrated genetic and environmental influences on abuse of individual substances, but there… 
Highly Cited
1989
Highly Cited
1989
Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs.
Phencyclidine (PCP), a dissociative anesthetic and widely abused psychotomimetic drug, and MK-801, a potent PCP receptor ligand… 
Review
1986
Review
1986
Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens.
  • D. E. Nichols
  • Journal of psychoactive drugs
  • 1986
  • Corpus ID: 29767383
The widc,pre.ld u e of psychedelic drug • ,>uch a Iy t:rgic acid dit:lh) IJmide (LSD), dunng Ihe 1960's and 1970' led 10 ev re… 
Highly Cited
1959
Highly Cited
1959
Study of a new schizophrenomimetic drug; sernyl.
Introduction The production of model psychoses has been employed as a technique for testing hypotheses relevant to the causes… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License